|Event Date/Time: Dec 07, 2008||End Date/Time: Dec 11, 2008|
During the five days of the conference, an unparalleled international faculty of more than 60 leading scientists will present their latest research results on advances in basic and applied antibody and binder engineering, and their therapeutic development. Participants will be able to network with more than 700 colleagues, explore exhibits showcasing new research technologies, and interact with speakers as well as poster authors.
This yearâ€™s Keynote speakers have been leading pioneers in this field since its beginning, having contributed many of the advancements that engendered the current revolution in recombinant antibodies and their successful clinical application, making antibody therapy a major new area of modern medicine. Dr. Michael L. Neuberger, Ph.D., from the
MRC Laboratory of Molecular Biology, will discuss the evolving technologies of antibody engineering, and Professor Sherie Morrison, Ph.D., from UCLA, will discuss the versatility of antibodies for multiple applications.